Ocular Therapeutix (OCUL) News Today $12.52 +0.20 (+1.62%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$12.31 -0.21 (-1.67%) As of 04:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OCUL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Invesco Ltd. Reduces Holdings in Ocular Therapeutix, Inc. $OCUL3 hours ago | marketbeat.comOcular Therapeutix (NASDAQ:OCUL) Insider Sanjay Nayak Sells 1,885 SharesAugust 28 at 8:57 AM | insidertrades.comAlgert Global LLC Acquires New Stake in Ocular Therapeutix, Inc. $OCULAugust 28 at 4:21 AM | marketbeat.comOcular Therapeutix™ to Participate in September Investor and Scientific ConferencesAugust 27 at 8:42 AM | markets.businessinsider.comOcular Therapeutix, Inc. $OCUL Shares Sold by Vanguard Group Inc.August 26 at 3:20 AM | marketbeat.comEntryPoint Capital LLC Purchases New Shares in Ocular Therapeutix, Inc. $OCULAugust 24, 2025 | marketbeat.comDeutsche Bank AG Sells 197,895 Shares of Ocular Therapeutix, Inc. $OCULAugust 24, 2025 | marketbeat.comOcular Hypertension Pipeline Outlook Report 2025: Key 50+ Companies and Breakthrough Therapies Shaping the Future LandscapeAugust 15, 2025 | theglobeandmail.comOcular Therapeutix (NASDAQ:OCUL) Hits New 52-Week High - Should You Buy?August 12, 2025 | marketbeat.comEquities Analysts Offer Predictions for OCUL Q3 EarningsAugust 9, 2025 | marketbeat.comQ3 EPS Forecast for Ocular Therapeutix Reduced by AnalystAugust 9, 2025 | marketbeat.comOcular Therapeutix Earnings Call: Positive Outlook Amid Trial ProgressAugust 8, 2025 | theglobeandmail.comAnalysts Have Made A Financial Statement On Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) Second-Quarter ReportAugust 8, 2025 | uk.finance.yahoo.comOcular Therapeutix (NASDAQ:OCUL) Price Target Lowered to $20.00 at ScotiabankAugust 7, 2025 | marketbeat.comOcular Therapeutix (NASDAQ:OCUL) Price Target Raised to $15.00August 7, 2025 | marketbeat.comRaymond James Sticks to Their Buy Rating for Ocular Therapeutix (OCUL)August 6, 2025 | theglobeandmail.comOcular Therapeutix Inc (OCUL) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 6, 2025 | finance.yahoo.comOcular Therapeutix (NASDAQ:OCUL) Releases Earnings Results, Misses Expectations By $0.04 EPSAugust 6, 2025 | marketbeat.comOcular Therapeutix (NASDAQ:OCUL) Shares Gap Down Following Weak EarningsAugust 6, 2025 | marketbeat.comOcular Therapeutix, Inc. (NASDAQ:OCUL) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | insidermonkey.comOCUL Sales Drop 18%August 5, 2025 | fool.comOcular Therapeutix tumbles as Q2 results miss estimatesAugust 5, 2025 | investing.comOcular Therapeutix (NASDAQ:OCUL) Reaches New 1-Year High - Should You Buy?August 5, 2025 | marketbeat.comOcular Therapeutix, Inc. (OCUL) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.com3OCUL : What's Next: Ocular Therapeutix's Earnings PreviewAugust 5, 2025 | benzinga.comBanco Santander S.A. Has $1.35 Million Holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL)August 4, 2025 | marketbeat.comOcular Therapeutix, Inc. (NASDAQ:OCUL) Shares Sold by Allianz Asset Management GmbHAugust 4, 2025 | marketbeat.comVictory Capital Management Inc. Sells 52,721 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL)August 4, 2025 | marketbeat.comOcular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Rating of "Buy" from AnalystsAugust 4, 2025 | marketbeat.comOcular Therapeutix (OCUL) Expected to Announce Quarterly Earnings on WednesdayJuly 31, 2025 | marketbeat.comOcular Therapeutix (NASDAQ:OCUL) Reaches New 12-Month High - What's Next?July 29, 2025 | marketbeat.comNottingham Advisors Inc. Has $242,000 Position in Ocular Therapeutix, Inc. (NASDAQ:OCUL)July 28, 2025 | marketbeat.comOcular Therapeutix (NASDAQ:OCUL) Hits New 1-Year High - Here's What HappenedJuly 24, 2025 | marketbeat.comOcular Therapeutix™ to Participate in Upcoming Scientific ConferencesJuly 22, 2025 | globenewswire.comOcular Therapeutix, Inc. (NASDAQ:OCUL) Receives Consensus Recommendation of "Buy" from AnalystsJuly 10, 2025 | marketbeat.comOcular Therapeutix (NASDAQ:OCUL) Shares Up 5.5% - Here's What HappenedJuly 8, 2025 | marketbeat.com847,468 Shares in Ocular Therapeutix, Inc. (NASDAQ:OCUL) Purchased by Peregrine Capital Management LLCJuly 1, 2025 | marketbeat.comOcular Therapeutix (NASDAQ:OCUL) Stock Price Up 7.7% - What's Next?June 30, 2025 | marketbeat.comOcular Therapeutix (OCUL) Moves 8.6% Higher: Will This Strength Last? - NasdaqJune 27, 2025 | nasdaq.comOcular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused CompanyJune 26, 2025 | finance.yahoo.comOcular Therapeutixâ„¢ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused CompanyJune 26, 2025 | globenewswire.comOcular Therapeutix (NASDAQ:OCUL) Shares Gap Up - Here's WhyJune 24, 2025 | marketbeat.comDeltec Asset Management LLC Has $19.91 Million Holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL)June 21, 2025 | marketbeat.comOcular Therapeutix (NASDAQ:OCUL) shareholders have earned a 33% CAGR over the last three yearsJune 17, 2025 | uk.finance.yahoo.comAssenagon Asset Management S.A. Makes New Investment in Ocular Therapeutix, Inc. (NASDAQ:OCUL)June 17, 2025 | marketbeat.comOcular's Make-Or-Break Moment: Axpaxli Data Looms For Wet AMD Market (Upgrade)June 16, 2025 | seekingalpha.comOcular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025June 16, 2025 | globenewswire.comOcular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Rating of "Moderate Buy" from BrokeragesJune 15, 2025 | marketbeat.comCourier Capital LLC Boosts Holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL)June 10, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Position in Ocular Therapeutix, Inc. (NASDAQ:OCUL)June 8, 2025 | marketbeat.com Get Ocular Therapeutix News Delivered to You Automatically Sign up to receive the latest news and ratings for OCUL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OCUL Media Mentions By Week OCUL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCUL News Sentiment▼0.571.03▲Average Medical News Sentiment OCUL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCUL Articles This Week▼115▲OCUL Articles Average Week Get the Latest News and Ratings for OCUL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Ocular Therapeutix and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ROIV News Today GRFS News Today RVMD News Today RYTM News Today LEGN News Today RNA News Today AXSM News Today ABVX News Today NUVL News Today MRUS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OCUL) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocular Therapeutix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocular Therapeutix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access